Chocolate 101

Is Dark Chocolate Healthy? What the Research Says

By Oliver BennettPublished October 15, 2026Updated October 15, 202613 min read

The research behind “dark chocolate is healthy” is about cocoa flavanols, a group of compounds in the cocoa bean, and what it shows is narrow: a small, short-term effect on blood vessel function and blood pressure. The largest trial gave flavanols in capsules, and it didn’t significantly reduce heart attacks, strokes and other cardiovascular events overall. A bar brings those flavanols along with sugar, saturated fat and calories, and dark chocolate carries more cadmium and lead than milk chocolate. It’s a food you can enjoy, and nothing in the evidence makes it a treatment. This article summarizes research and regulators’ decisions; it isn’t medical advice.

What researchers mean by “dark chocolate is healthy”

Researchers test cocoa flavanols in measured amounts, and the products they use are built to deliver them, which is a different thing from the bar on a supermarket shelf. Dark chocolate is chocolate made mostly of cocoa solids and sugar with little or no milk; the names, minimums and what the cocoa percentage means are covered in types of chocolate.

The gap shows up in the regulators’ own numbers. When the European Food Safety Authority assessed cocoa flavanols in 2012, it set the effective amount at 200 mg a day and wrote, in its published opinion, that this “could be provided by 2.5 g of high‐flavanol cocoa powder or 10 g of high‐flavanol dark chocolate”. The word that matters there is “high-flavanol”. It describes a specially made product, and ordinary bar labels don’t declare flavanols at all.

In the petition the US Food and Drug Administration reviewed in 2023, high-flavanol cocoa powder meant at least 4% cocoa flavanols, and high-flavanol dark chocolate meant “at least 0.70% to about 2.6%” of them. Those definitions came from the company asking for the claim.

The biggest trial skipped chocolate entirely. The COSMOS researchers gave a cocoa extract in capsules because they wanted to test something that “preserves the known bioactive contents of the cocoa bean without adding excessive sugar, saturated fat, and calories”, as they explain in their trial report. They also note that processing, the chain of steps in how chocolate is made, changes those bioactive contents, and alkalization, also known as Dutch processing, is one such step. A higher percentage on the wrapper isn’t evidence of more flavanols in the bar.

The evidence, claim by claim

The strongest evidence is for blood vessel function and blood pressure, and it comes from flavanol-rich products rather than ordinary bars. The table maps each claim to its best source, what was actually given to people, and who paid. Details and links follow in the sections below.

Blood vessels and blood pressure

Cocoa flavanols have a small, measurable effect here, and it’s the one place where the EU allows a health claim. The authorized wording, in Regulation 851/2013 as adopted, reads: “Cocoa flavanols help maintain the elasticity of blood vessels, which contributes to normal blood flow”. It comes with conditions. The consumer has to be told that the benefit comes with 200 mg of cocoa flavanols a day, and the claim can only go on cocoa drinks or dark chocolate that actually deliver that amount. A 2015 amendment extended it to capsules and tablets of high-flavanol cocoa extract.

The claim has a commercial origin. A cocoa and chocolate supplier applied for it, and the regulation’s own recitals say EFSA’s conclusion “could not have been reached without considering one human intervention study claimed by the applicant as proprietary”. The evidence behind this claim started with the company that wanted to use it.

On blood pressure, the most cited source is a 2017 Cochrane review of 35 trials with 1,804 mostly healthy people. It found “moderate-quality evidence that flavanol-rich chocolate and cocoa products cause a small (2 mmHg) blood pressure-lowering effect in mainly healthy adults in the short term.” The trials ran from two to 18 weeks. When the reviewers left out trials whose authors were employed by the sponsoring company, the effect got a little smaller, which they read as a sign of “some reporting bias”. People who already had high blood pressure saw systolic pressure drop by about 4 mmHg, against no significant difference in people with normal readings, though that comparison between subgroups was only of borderline significance.

A newer meta-analysis lands in the same place. The 2026 review by Sakuda and colleagues pooled 25 trials and found systolic pressure 2.7 mmHg lower, with moderate certainty for that outcome and limited certainty for the rest. A chocolate maker funded it, and five of its authors work for that company.

Regulators haven’t always agreed. In 2010, EFSA looked at a general claim that cocoa flavanols maintain normal blood pressure and called the evidence “insufficient to establish a cause and effect relationship”, noting that small, unblinded studies conflicted with larger, better controlled ones. That opinion predates the 2017 Cochrane review.

Heart attacks and strokes: what the big trial found

The largest trial didn’t find a significant reduction in total cardiovascular events, and it didn’t use chocolate. COSMOS enrolled 21,442 US adults, women aged 65 and up and men aged 60 and up, and gave half of them two capsules a day of cocoa extract containing 500 mg of flavanols. Over about 3.6 years, 410 people on cocoa extract and 456 on placebo had a confirmed cardiovascular event, a hazard ratio of 0.90 with a confidence interval of 0.78 to 1.02, which isn’t statistically significant.

Deaths from cardiovascular disease were lower in the cocoa extract group, with a hazard ratio of 0.73 (0.54 to 0.98). That was a secondary outcome. The trial report concludes that the extract “did not significantly reduce total cardiovascular events among older adults but reduced CVD death by 27%”, and that more research is needed. The trial was paid for partly by the nutrition research arm of a chocolate company, which also donated the pills, and partly by the US National Institutes of Health. The authors state that the company had no role in the trial design, data analysis or writing, apart from blinded lab assays it supported.

Observational studies point the same weak way. A 2020 meta-analysis by Morze and colleagues pooled 27 studies that followed people’s diets over time. Each extra 10 g a day of reported chocolate intake was associated with a slightly lower rate of coronary heart disease (relative risk 0.96) and stroke (0.90). The authors rated the credibility of that evidence as low, and none of the studies’ diet questionnaires separated dark chocolate from milk. Studies like these show an association. They can’t show that chocolate caused anything.

The US regulator drew a tight line. In 2023 the FDA answered a petition that asked for a heart claim on both high-flavanol cocoa powder and high-flavanol dark chocolate. Its response letter allowed a qualified claim for the cocoa powder only, based on two studies with 20 and 42 people that lasted one and three weeks. The permitted wording is: “Cocoa flavanols in high flavanol cocoa powder may reduce the risk of cardiovascular disease, although FDA has concluded that there is very limited scientific evidence for this claim.”

For dark chocolate, the same letter says “no credible studies were identified” supporting a link with lower cardiovascular risk, because the bar has “much higher levels of calories, total fat, and saturated fat than cocoa powder, which could influence the effects on CVD risk.” The FDA also said the evidence doesn’t support a daily intake of 200 mg of cocoa flavanols “or any other daily dietary intake recommendation levels for the general U.S. population.” The letter is an exercise of enforcement discretion rather than an approval, and it covers cocoa powder only.

Memory, mood and the brain

The trials on the brain didn’t find the effects the headlines promise. In the COSMOS-Mind study of 2,262 participants over three years, cocoa extract “did not reduce risks for cognitive impairment”, although the authors note the study’s statistical power was low.

COSMOS-Web tested memory in 3,562 participants. Its main result, memory improvement across everyone after a year, wasn’t statistically significant. In a subgroup of people whose usual diet was low in quality or in flavanols, the researchers reported that the flavanol capsules “restored memory”. A subgroup finding like that is a lead for the next trial. It isn’t evidence that chocolate sharpens anyone’s memory.

Mood fared no better with regulators. In 2011 EFSA assessed a claim that the caffeine and theobromine in cocoa enhance mood and concluded, in its opinion, that “a cause and effect relationship has not been established”.

Weight and blood sugar

Cocoa and dark chocolate don’t change body weight in trials. A 2019 meta-analysis of 35 trials found no significant effect on weight, BMI or waist size. The pooled weight change was −0.108 kg, with a confidence interval that included zero.

The 2024 meta-analysis by Arisi and colleagues, which had no external funding, pooled 31 trials of cocoa extract or chocolate of 70% cocoa and up. It found no effect on weight, BMI, waist, triglycerides, HDL cholesterol or HbA1c. LDL cholesterol was 9.5 mg/dL lower and fasting blood sugar 4.9 mg/dL lower, both rated moderate quality. These are small shifts in lab values, measured in trials that ran for weeks.

For type 2 diabetes there’s only observational data. In the Morze meta-analysis, chocolate intake showed no clear association with the disease (relative risk 0.94, with an interval of 0.88 to 1.01), and the credibility of that evidence was rated very low.

Antioxidants, ORAC and the “superfood” label

The antioxidant claim was tested by the EU regulator and rejected. In its 2010 opinion, EFSA found that “a cause and effect relationship has not been established between the consumption of cocoa flavanols and protection of lipids from oxidative damage”. An effect seen in one short study didn’t hold up when people ate cocoa flavanols daily for three to six weeks. The same opinion dismissed ORAC, the lab score often quoted for “antioxidant power”, as “not an acceptable way of characterising a food” for a health claim.

The US Department of Agriculture went further. In 2012 it removed its ORAC database, citing “mounting evidence that the values indicating antioxidant capacity have no relevance to the effects of specific bioactive compounds, including polyphenols on human health”, and noting that the values were “routinely misused” by food and supplement companies to promote their products.

Labels like “superfood” run into EU rules on general wording. Under Article 10(3) of the EU claims regulation, a reference to a food’s general benefits for overall health “may only be made if accompanied by a specific health claim” from the authorized lists. For cocoa flavanols, that specific claim is the blood flow one, with its 200 mg condition.

What a bar brings with it

A bar of dark chocolate is high in calories and fat, and its sugar content can vary a lot between bars. The figures below come from one database entry, USDA FoodData Central record 170273, “Chocolate, dark, 70-85% cacao solids” (SR Legacy, 2019). They’re averages for that entry, and your bar’s label will differ.

Per 100 g, that entry lists 598 kcal, 42.63 g of fat (24.489 g of it saturated), 10.9 g of fiber, 80 mg of caffeine and 802 mg of theobromine. It also lists 11.9 mg of iron and 228 mg of magnesium.

Sugar is the number to treat with care. The entry gives 24 g per 100 g, but that figure rests on just two analyses, which measured 14.5 g and 30.3 g. That spread sits inside a single 70 to 85% category, so the nutrition panel on the bar you’re holding is the only figure that applies to it.

None of this was what the flavanol trials tested. It’s the reason the COSMOS team used capsules, and the reason the FDA gave for refusing a dark chocolate claim. If you eat dark chocolate for the taste, how to taste chocolate gets more out of each piece.

Cadmium and lead in dark chocolate

Dark chocolate contains more cadmium and lead than milk chocolate, because both metals sit in the cocoa solids. Regulators treat them as contaminants to be kept low. Neither the EU nor the FDA treats their presence as a reason to stop selling chocolate.

The EU sets maximum cadmium levels for chocolate that rise with cocoa content, so the highest limit applies to bars with 50% cocoa solids or more; the full table is in chocolate food safety. The same EU contaminants regulation, 2023/915, has no lead limit for chocolate in the text as first published.

The FDA explains the lead gap between dark and milk in its supporting document on lead in candy: “chocolate liquor is the principal source of lead in chocolate products”, and dark chocolate contains more of it. In industry data from 2005, dark chocolate samples averaged 0.048 ppm of lead against 0.028 ppm for milk chocolate, and several dark samples went above 0.1 ppm. That 0.1 ppm figure is FDA guidance for candy that small children are likely to eat often. It isn’t a legal limit for chocolate bars.

The FDA’s lead page also states that “no safe level for lead exposure has been identified”. Whether a given product can be sold is a separate question. In the 2023 claim letter, the agency wrote that individual cocoa products found to be contaminated in violation of the law can’t be sold, while cocoa products as a category are generally recognized as safe.

Cadmium levels, according to the FDA’s cadmium page, “depend on the growing area and the percentage of cocoa solids in the chocolate product.” The same page quotes a 2021 WHO assessment that cocoa products made up a minor share of dietary cadmium, between 0.1% and 9.4% in national studies, even in countries where cocoa consumption is relatively high.

Origin plays a part. An FDA survey of US retail products found cadmium and lead both rose with the percentage of cocoa, and cadmium was higher in products reported as coming from Latin America than from Africa. How origins differ in flavor is in cocoa origins compared.

The figures that made the news came from consumer testing. In December 2022, Consumer Reports tested 28 dark chocolate bars and detected cadmium and lead in all of them. For 23 of the bars, it calculated that eating one ounce a day would put an adult over its benchmark for at least one of the two metals, and five bars went over for both. The benchmark was California’s maximum allowable dose level, 0.5 micrograms for lead and 4.1 micrograms for cadmium. Consumer Reports itself says its results show which products had comparatively higher levels and “are not assessments of whether a product exceeds a legal standard.”

Sources and open questions

• COSMOS trial (Sesso and colleagues, 2022), American Journal of Clinical Nutrition: funded by an investigator-initiated grant from Mars Edge, the nutrition research segment of Mars, which donated the study pills, and by NIH grants. COSMOS-Web lists Mars Edge among its grants; COSMOS-Mind was NIH funded.
• EU cocoa flavanol claim: applicant Barry Callebaut Belgium nv, both for the original opinion and for the 2014 extension to capsules in EFSA 2014. The EFSA 2012 and 2014 opinions were read as abstracts.
• FDA 2023 qualified health claim: petition submitted on behalf of Barry Callebaut AG, response letter of February 1, 2023.
• Sakuda and colleagues 2026: funded by Meiji Co., Ltd.; five authors work in Meiji’s research and development.
• Morze 2020 and Arisi 2024 declare no funding.
• Regulation 2015/539 (extension of the claim to extract capsules and tablets): as adopted.
• California’s maximum allowable dose levels were taken from Consumer Reports’ article; the state’s own list wasn’t accessible.
• Open: how many flavanols an ordinary retail dark bar contains. The regulator and review sources used here give no figure, and labels don’t declare it.
• Open: the current consolidated EU texts (the cocoa flavanol claim, the lead section of 2023/915) are checked on publication day.